Section Arrow
Quote
GRFS.NASDAQ
- Grifols SA
Quotes are at least 15-min delayed:2026/03/09 20:35 EDT
Regular Hours
Last
 8.76
+0.17 (+1.98%)
Day High 
8.77 
Prev. Close
8.59 
1-M High
9.77 
Volume 
65.66K 
Bid
8.24
Ask
9.43
Day Low
8.425 
Open
8.49 
1-M Low
8.2801 
Market Cap 
5.85B 
Currency 美元 
P/E 13.52 
%Yield 2.01 
10-SMA 8.9 
20-SMA 9.15 
50-SMA 9.18 
52-W High 11.14 
52-W Low 6.19 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
0.55/1.00
Enterprise Value
15.29B
Balance Sheet
Book Value Per Share
8.83
Cash Flow
Cash Flow Yield
0.23
Income Statement
Total Revenue
3.36B
Operating Revenue Per Share
10.17
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
MDCXMedicus Pharma Ltd0.5099+0.1247+32.37%-- 
PFEPfizer26.81-0.24-0.89%19.84PE
NVONovo-Nordisk A/S39.78+1.2+3.11%10.75PE
BMYBristol-Myers Squibb Co60.63+0.34+0.56%17.41PE
MRKMerck & Co117.11+1.32+1.14%15.9PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.